Novel

Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down

For patients with high-risk breast cancer treated with radical mastectomy and adjuvant chemotherapy, the addition of radiation therapy leads to better survival outcomes with few long-term toxic effects, according to a 20-year follow-up of a randomized trial, which appears in the January 19 issue of the Journal of the National Cancer Institute. The British Columbia randomized radiation the...

Novel technology detects human DNA mutations

Researchers at today reported unprecedented benefits in the company's technology for the medical analysis of human DNA. genotyping...

Novel antiviral technology inhibits RSV infection in mice

A novel antiviral treatment combiningnanoparticle and gene silencing technologies thwarts attacks ofrespiratory syncytial virus (RSV) -- a virus associated with severebronchitis and asthma, an animal study by University of South Floridaresearchers found. The study was reported in the January 2005 issue ofthe journal Nature Medicine.RSV infects lung cells and can be life-threatening in very...

Novel Enzyme Shows Potential As An Anti-HIV Target

At just 9.8 kilobases, the HIV genome pales in comparison to the 3.2 gigabases of its human and nonhuman primate targets. The compact retrovirus encodes just 14 proteins, which play different roles in promoting viral infection and virulence. As a retrovirus, HIV uses the host’s cellular machinery—including RNA polymerases, which carry out transcription—to copy its RNA genome into DNA and infiltra...

Novel Therapy Tested in Mice Could Chase Away Cat Allergies

A molecule designed to block cat allergies successfully prevented allergic reactions in laboratory mice, as well as in human cells in a test tube, University of California, Los Angeles (UCLA) researchers report in the April issue of Nature Medicine, available online now. In the future, the investigators say, these promising results could lead to a new therapy not only for human cat allergies, but...

More>>

Novel at Biology Products

Spatial Behavior System, Novel Object from myNeuroLab.com

Description:Novel Object Records behavior directed toward examining a novel object in the environment.The Spatial Behavior line is a family of instruments all built around a video camera, frame grabber, and feature extraction software and that can track two fields at once and up to 6 moving animals. Software automatically extracts animal positions and records them, but also allows video replay of all or mac...
Company:myNeuroLab.com

Novel at Biology Technology

Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase

pfuturbo DNA polymerase for robust, high-fidelity PCRamplification Holly Hogrefe Brad Scott Kirk Nielson ValerieHedden Connie Hansen Janice Cline Frances Bai Jeff Amberg RondaAllen Mark Madden Stratagene an improved version of Pf...

High-Fidelity PCR with a Novel Polymerase Mixture

New polymerase mixture, TaqPlus Precision PCR system, developed forhighfidelity PCR Kirk B. Nielson * Janice Cline * Frances Bai * Daniel McMullan* Barbara McGowan * Holly Hogrefe Stratagene Cloning Systems, Inc. Stratagene announces the addition of the TaqPlus Precision PCR system,* to an expanding line...

Challenge the Performance of Your Hot-Start PCRs with FastStart Taq DNA Polymerase and the Novel FastStart High Fidelity PCR System

FastStart Taq DNA Polymerase, a chemically modified versionof Taq DNA Polymerase for hot start PCR, was introducedin 2000. Based on the feedback from many customers,FastStart Taq DNA Polym...

Combine High Yield, Great Accuracy and the Prevention of Carry-over Contamination by Using the Novel Expand High FidelityPLUS PCR System

Roche Applied Science pioneered the blending of thermostableDNA polymerases and the associated buffersystems. The well-known Expand High Fidelity andExpand Long Template PCR Systems were the first commerciallyavailable blends to provide amplification offragments up t...

Novel MicroRNA Array Technology for Sensitive miRNA Profiling

The miRNA gene family contains hundreds of translation regulators, yet their presence and function has only recently been reported in the literature (see <A...

More>>

Novel at Medicine News

Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched

Cyclosporine has revolutionised the transplantation scene in the last 20 years by helping with immunosuppresion. Novartis have so far had the patent for the drug and enjoyed the profits. The cost of the medicine is prohibitively expensive.However in the past few years other pharma companies have been allowed to manufacture the drug giving Novartis a competetion. The current tablet size are big an...

A novel augmentation

Scientists from Japan have augmented the cells of frog eyes and ears in a test tube, in the erstwhile step towards grow-your-own organs.The mode uses special cells taken from frog embryos called stem cells. These have the potential to develop into any specific type of cell in the frog's body - heart, skin, muscle and so on.// The major technique used by the team at Tokyo University is...

Novel biopsy technique for prostate cancer

Recently a more extensive biopsy detecting technique for prostate cancers has been found out by researchers.// This is very effective than the traditional examination. In the traditional exam for prostate cancer, the doctor takes six tissue samples from the prostate gland. At Ohio State University, researchers said that it is better to take more samples. Dr.Robert Bahnson and...

Novel computer model for breast cancer

A worldly-wise computer model can forecast which breast cancers will spread and so need aggressive treatment. Researchers at University of Hopkins, have developed a neural network system - where a computer is taught to spot patterns //- in combination with fuzzy logic, a way of modeling the uncertainty of natural language. The result is a model which can scrutinize images of breast cancer cells,...

Novel research on liver cancer

A new study contributes to the findings of liver cancer. Investigators at Johns Hopkins University School of Medicine report findings on a potential new treatment for this ghastly cancer. In the study, researchers injected a compound called 3-bromopyruvate// directly into the artery that leads to the cancerous tumor. They say it did not adversely affect the healthy portion of the liver or surroun...

More>>

Novel at Medicine Products

No data found

Search Novel medicine products at Google

Search Novel medicine products at Yahoo

Search Novel medicine products at Msn

Novel at Medicine Technology

Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis

RESEARCH TRIANGLE PARK, N.C. & SHERBROOKE, Quebec--(BUSINESSWIRE)--Jun 26, 2007 - Tranzyme Pharma, a leading biopharmaceuticalcompany developing small molecule drugs for the treatment ofgastrointestinal and metabolic diseases, today announced positiveresults for its novel ghrelin agonist, TZP-101, in acceleratinggastric emptying in diabetic patients with gastroparesis. The datafrom a pi...

Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science

- Journal Article Also Demonstrates the Promise of Anacor'sBoron-Based Chemistry in Developing Antibiotics - PALO ALTO, Calif., June 21, 2007 /PRNewswire/ -- AnacorPharmaceuticals, a privately held pharmaceutical company, announcedtoday that the journal Science will publish results of researchthat details how AN2690, the company's lead clinical candidate,kills fungal cells by interfering...

Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care

NEWTON, Mass.--(BUSINESS WIRE)--Jun 18, 2007 - NovelosTherapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical companyfocused on the development of therapeutics to treat cancer andhepatitis, today announced encouraging results in an ongoingDana-Farber/Partners Cancer Care (DF/PCC) Phase 2 trial of NOV-002in combination with carboplatin in platinum-resistant ovariancancer patients. To date, 10...

Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action

SALT LAKE CITY, June 14, 2007 /PRNewswire/ -- ProlexysPharmaceuticals and announced today a publication describing theproperties of the selective small molecule anti-tumor agent,erastin. Prolexys and Columbia applied the company'schemi-proteomics technology to understand the mechanism of actionof erastin. The results, to be published in the June 14, 2007 issueof the journal Nature reveal...

Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood

Preclinical Studies Show 227Th-rituximab More Effective atKilling CD20-Positive Lymphoma Cells Than 90Y-tiuxetan-ibritumomab(Zevalin) OSLO, Norway, 14 June 2007 - Algeta ASA (OSE: ALGETA), theNorwegian cancer therapeutics company, announces that a researchpaper showing the potential of its TH-1 technology for targetedcancer therapy has been published by the leading medical journal,...

More>>